U.S. overdose death rates declined between 2023 and 2024, marking the first recorded drop in all four waves of the nation’s overdose crisis. However, overdose deaths involving stimulants without fentanyl, and xylazine-related deaths, continue to rise and racial disparities remain severe.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
